Congress mandates transparency in research funding for underserved states
S. 2005 — IDeA Reauthorization Act of 2025 · Filed by Cindy Hyde-Smith (R-MS) · 3 cosponsors · Introduced Jun 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill reauthorizes and improves the NIH's Institutional Development Award (IDeA) program, which funds biomedical research in states that receive below-median federal research funding. The bill formally names the program, clarifies eligibility based on a rolling multi-year funding average, and requires NIH to report annually to Congress on program strategy, awards made, reviewer diversity, interstate collaborations, and long-term research quality gains.
Why we flagged it
The bill's core function is to reauthorize and improve transparency in a federal research-equity program. It does not create new funding streams or change appropriations; instead, it formalizes program structure, clarifies eligibility criteria, and mandates public reporting on outcomes and diversity metrics.
What the text implies
- The rolling multi-year average methodology for determining 'IDeA State' status may shift eligibility over time, potentially affecting which states qualify for preferential funding in future years.
- Mandatory reporting on 'percentage of IDeA program reviewers from IDeA States' creates a new diversity metric that could influence peer-review composition and may indirectly affect grant-award patterns.
The full analysis lists 3 implications of this text.
Who stands to gain
Research institutions in below-median-funded states; Universities and biomedical research centers in IDeA-eligible states